Dr. Hans Nyctelius has been a Partner at Roland Berger’s Stockholm office since 2010, . He has led and participated in more than 250 international strategy and business assignments, covering broad areas of strategy, investments, business development, sales force optimization and market assessments as well as research & development and organizational work. Hans has broad experience in the pharmaceutical, med-tech & healthcare and consumer goods & retail industries, where he has variously worked as a management consultant, senior executive and medical doctor. He has supported more than 50 international investors on both sell- and buy-side mandates and IPO preparations. Before entering consulting, Hans spent more than a decade working as a medical doctor as well as 5 years as COO of Q­Med and CEO of SwedenBIO. He holds a medical degree from Lund University in Sweden, an MBA with distinction from the Warwick Business School in the UK and is a Certified Financial Analyst (CFA).